Lisa Gill, Managing Director at J.P. Morgan and head of healthcare services research, discusses key insights into the healthcare sector, particularly around M&A activities. She delves into shifting corporate strategies influenced by changes in the political landscape, highlighting significant mergers post-Trump. Additionally, the implications of a potential TikTok ban on stock markets are explored, alongside valuable analyses of drug distributors and CVS's Medicare Advantage performance. Lisa's expertise shines as she navigates the complex intersections of healthcare and finance.